Winston Laboratories   Report issue

For profit Phase 3
Founded: Vernon Hills IL United States (1998)
Status: No NME R&D (1998)

Organization Overview

First Clinical Trial
2002
NCT00033839
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

sodium chloride (1 trial)

zucapsaicin (10 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cluster Headache (Phase 3)

Dry Eye Syndromes (Phase 2)

Headache (Phase 3)

Keratoconjunctivitis Sicca (Phase 2)

Neuralgia (Phase 2)

Neuralgia, Postherpetic (Phase 2)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 10
  • # of Trial APIs: 2